GlassScriptPhysician profile
Jamal F Rabbi
NPI 1457506388
$7,379.07
in general payments reported to CMS, 2019-2025
11 companies · $5,845 in 2025
The $5,845 reported for 2025 was more than what 84% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,534 · 2025: $5,845.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,723 · Food and Beverage: $1,122.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,723.08 |
| Food and Beverage | $1,121.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $2,386.39 | 2025 | Indigo System |
| Boston Scientific Corporation | $2,377.19 | 2025 | Jetstream Sc, General - Angiography, Ekosonic |
| Abiomed | $947.04 | 2025 | |
| Terumo Medical Corporation | $652.00 | 2019 | |
| Medtronic Vascular, INC. | $469.27 | 2019 | |
| Endologix LLC | $383.95 | 2019 | |
| Stryker Corporation | $84.96 | 2025 | Na, Stryker Varispeed |
| Lsi Solutions INC | $28.98 | 2019 | |
| Atricure, INC. | $19.31 | 2025 | Synergy Ablation System, Atriclip Laa Exclusion System |
| Chiesi USA, INC. | $15.04 | 2025 | Kengreal |
| Edwards Lifesciences Corporation | $14.94 | 2025 | Inspiris Resilia Aortic Valve |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jamal Rabbi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.